Thursday 27 January 2022
Home      All news      Contact us      RSS      India
dailyexcelsior.com - 13 days ago

Glenmark gets USFDA nod for nasal spray to treat seasonal allergic rhinitis

New Delhi, Jan 14: Glenmark Pharmaceuticals on Friday said its subsidiary has received approval from the US health regulator to market Ryaltris, a nasal spray for the treatment of seasonal allergic rhinitis. The company s fully-owned unit Glenmark Specialty SA (Switzerland) has received approval from the USFDA for its new drug application (NDA) for Ryaltris, a fixed-dose (metered), prescription, combination nasal spray, Glenmark Pharmaceuticals said in a statement. The product is used for the treatment of symptoms of seasonal allergic rhinitis [ ] The post Glenmark gets USFDA nod for nasal spray to treat seasonal allergic rhinitis appeared first on Jammu Kashmir Latest News | Tourism | Breaking News J K.


Latest News
Hashtags:   

Glenmark

 | 

USFDA

 | 

nasal

 | 

spray

 | 

treat

 | 

seasonal

 | 

allergic

 | 

rhinitis

 | 

Sources